HLA, NFKB1 and NFKBIA Gene Polymorphism Profile in Autoimmune Diabetes Mellitus Patients

Abstract

Type 1 diabetes mellitus (T1DM) is one of the long-time studied autoimmune disorders. The triggering of the autoimmune process has been ascribed to various genes active in the regulation of the cytokine gene transcription including the Rel/NF-κB gene family. In our study the gene polymorphism of HLA class II, NFKB1 (nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) and NFKBIA (inhibitor of nuclear factor kappa B) was tested. Patients were divided into the subgroups in relation to the disease type: T1DM in children, T1DM in adults, and Latent Autoimmune Diabetes in Adults (LADA). HLA-DRB1^*04 and HLA-DQB1^*0302 have been detected as risk factors for T1DM in adults and particularly in children (P<0.0001, OR=22.9 and 46.5 respectively). HLA-DRB1^*03 has been found as a single risk factor for LADA (P<0.0001, OR=4.9). We detected 15 alleles for the NFKB1 gene polymorphism (CA-repeats) in the Czech population. The alleles were ranging in size from 114-142 bp corresponding to 10-25 CA repeats. Frequency of the A7 allele of NFKB1 gene has been significantly increased in T1DM adults (P<0.01). There was no difference in A and a G allele frequency of NFKBIA gene between the control group and patients, but the association of the AA genotype of NFKBIA gene has been found for LADA (P<0.05). Summarizing our results we concluded that there is a high probability of association of gene polymorphism from Rel/NF-κB family with an autoimmune diabetes course. Due to the results obtained in the epidemiological study we have been looking also for the function significance of the genetic predisposition. No significant changes have been observed by real time PCR testing of HLA-DRB1^*04 gene and NFKB1 gene expression between T1DM diabetic group with different HLA, NFKB1, NFKBIA genetic background.

Key words

T1DM - HLA - NFKB1 - NFKBIA - LADA

References

• 1 Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M. IKK-beta links inflammation to obesity-induced insulin resistance.  Nat Med. 2005;  11 191-198
• 2 Baldwin Jr. AS. Series introduction: the transcription factor NF-kappaB and human disease.  J Clin Invest. 2001;  107 3-6
• 3 Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.  N Engl J Med. 1997;  336 1066-1071
• 4 Bierhaus A, Schiekofer S, Schwaninger M, Andrassy M, Humpert PM, Chen J, Hong M, Luther T, Henle T, Kloting I, Morcos M, Hofmann M, Tritschler H, Weigle B, Kasper M, Smith M, Perry G, Schmidt AM, Stern DM, Haring HU, Schleicher E, Nawroth PP. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB.  Diabetes. 2001;  50 2792-2808
• 5 Borm ME, van Bodegraven AA, Mulder CJ, Kraal G, Bouma G. A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis.  Int J Immunogenet. 2005;  32 401-405
• 6 Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB.  Nat Med. 2005;  11 183-190
• 7 Cerna M, Novota P, Kolostova K, Cejkova P, Zdarsky E, Novakova D, Kucera P, Novak J, Andel M. HLA in Czech adult patients with autoimmune diabetes mellitus: comparison with Czech children with type 1 diabetes and patients with type 2 diabetes.  Eur J Immunogenet. 2003;  30 401-407
• 8 Chen F. Is NF-kappaB a culprit in type 2 diabetes?.  Biochem Biophys Res Commun. 2005;  332 1-3
• 9 Cinek O, Kolouskova S, Snajderova M, Sumnik Z, Sedlakova P, Drevinek P, Vavrinec J, Ronningen KS. HLA class II genetic association of type 1 diabetes mellitus in Czech children.  Pediatr Diabetes. 2001;  2 98-102
• 10 Csorba TR, Lyon AW. Abnormal proinsulin congeners as autoantigens that initiate the pathogenesis of Type 1 diabetes.  Med Hypotheses. 2005;  64 186-191
• 11 Curran JE, Weinstein SR, Griffiths LR. Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA, and their involvement in sporadic breast cancer.  Cancer Lett. 2002;  188 103-107
• 12 Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes.  Endocr Rev. 2002;  23 599-622
• 13 Gylvin T, Bergholdt R, Nerup J, Pociot F. Characterization of a nuclear-factor-kappa B (NFkappaB) genetic marker in type 1 diabetes (T1DM) families.  Genes Immun. 2002;  3 430-432
• 14 Haslbeck KM, Schleicher E, Bierhaus A, Nawroth P, Haslbeck M, Neundorfer B, Heuss D. The AGE/RAGE/NF-(kappa)B pathway may contribute to the pathogenesis of polyneuropathy in impaired glucose tolerance (IGT).  Exp Clin Endocrinol Diabetes. 2005;  113 288-291
• 15 Hayden MS, Ghosh S. Signaling to NF-kappaB.  Genes Dev. 2004;  18 2195-2224
• 16 Hegazy DM, O’Reilly DA, Yang BM, Hodgkinson AD, Millward BA, Demaine AG. NFkappaB polymorphisms and susceptibility to type 1 diabetes.  Genes Immun. 2001;  2 304-308
• 17 Heron E, Deloukas P, van Loon AP. The complete exon-intron structure of the 156-kb human gene NFKB1, which encodes the p105 and p50 proteins of transcription factors NF-kappa B and I kappa B-gamma: implications for NF-kappa B-mediated signal transduction.  Genomics. 1995;  30 493-505
• 18 Jaini R, Kaur G, Mehra NK. Heterogeneity of HLA-DRB1*04 and its associated haplotypes in the North Indian population.  Hum Immunol. 2002;  63 24-29
• 19 Karban AS, Okazaki T, Panhuysen CI, Gallegos T, Potter JJ, Bailey-Wilson JE, Silverberg MS, Duerr RH, Cho JH, Gregersen PK, Wu Y, Achkar JP, Dassopoulos T, Mezey E, Bayless TM, Nouvet FJ, Brant SR. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis.  Hum Mol Genet. 2004;  13 35-45
• 20 Lechler RI, Norcross MA, Germain RN. Qualitative and quantitative studies of antigen-presenting cell function by using I-A-expressing L cells.  J Immunol. 1985;  135 2914-2922
• 21 Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.  Methods. 2001;  25 402-408
• 22 Novota P, Cerna M, Kolostova K, Cejkova P, Zdarsky E, Novakova D, Kucera P, Novak J, Andel M. Diabetes mellitus in adults: association of HLA DRB1 and DQB1 diabetes risk alleles with GADab presence and C-peptide secretion.  Immunol Lett. 2004;  95 229-232
• 23 Ota N, Nakajima T, Shirai Y, Emi M. Isolation and radiation hybrid mapping of a highly polymorphic CA repeat sequence at the human nuclear factor kappa-beta subunit 1 (NFKB1) locus.  J Hum Genet. 1999;  44 129-130
• 24 Rewers A, Babu S, Wang TB, Bugawan TL, Barriga K, Eisenbarth GS, Erlich HA. Ethnic differences in the associations between the HLA-DRB1*04 subtypes and type 1 diabetes.  Ann N Y Acad Sci. 2003;  1005 301-309
• 25 Rueda B, Lopez-Nevot MA, Ruiz MP, Ortega E, Maldonado J, Lopez M, Martin J. CA microsatellite polymorphism of the nuclear factor kappa B1 gene in celiac disease.  Eur J Immunogenet. 2004;  31 129-132
• 26 Shawkatova I, Fazekasova H, Michalkova D, Martinka E. Association of type I diabetes mellitus with HLA alleles].  Bratisl Lek Listy. 2000;  101 624-625
• 27 Smyth DJ, Howson JM, Payne F, Maier LM, Bailey R, Holland K, Lowe CE, Cooper JD, Hulme JS, Vella A, Dahlman I, Lam AC, Nutland S, Walker NM, Twells RC, Todd JA. Analysis of polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases.  BMC Med Genet. 2006;  7 20
• 28 Wheat W, Kupfer R, Gutches DG, Rayat GR, Beilke J, Scheinman RI, Wegmann DR. Increased NF-kappa B activity in B cells and bone marrow-derived dendritic cells from NOD mice.  Eur J Immunol. 2004;  34 1395-1404
• 29 World Health Organization Definition .Diagnosis and Classification of Diabetes Mellitus and its Complications. Geneva, Switzerland: Department of Noncommunicable Disease Surveillance. WHO 1999

1 Funding sources: The project was supported by MSM 0021620814

Correspondence